EMV CAPITAL PLC
Venture capital investor building a portfolio of deep tech and life science companies.
EMVC | IL
Overview
Corporate Details
- ISIN(s):
- GB00BN4R5Q82
- LEI:
- 213800N5WD46G1Y7I458
- Country:
- United Kingdom
- Address:
- London End, HP9 2JH Beaconsfield
- Website:
- https://www.emvcapital.com/
- Sector:
- Financial and insurance activities
- Industry:
- Fund management activities
Description
EMV Capital PLC is a venture capital investment group specializing in deep tech and life sciences. The firm identifies, invests in, and builds an international portfolio of high-growth companies with a strategic focus on industrial technology, healthcare, and sustainability. EMV Capital employs a capital-efficient investment strategy, utilizing a combination of syndicated investments, balance sheet funds, and fund management to support companies from early stages through to exit. Its model is distinguished by proactive portfolio management, where it takes an active, engaged role by securing board positions and providing comprehensive value creation services, including fundraising support, IP strategy, and exit readiness. The company was formerly known as NetScientific plc.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-22 08:00 |
M&A Activity
Asset Purchase Agreement with Destiny Pharma
|
English | 21.5 KB | ||
| 2025-09-18 08:00 |
Report Publication Announcement
Notice of Interim Results
|
English | 15.4 KB | ||
| 2025-08-21 15:33 |
Report Publication Announcement
Board meeting to approve unaudited interim financial statements
|
English | 462.5 KB | ||
| 2025-06-30 13:22 |
Post-Annual General Meeting Information
Result of AGM
|
English | 30.8 KB | ||
| 2025-06-30 08:00 |
Regulatory News Service
Office move and Related Party Transaction
|
English | 16.8 KB | ||
| 2025-06-10 14:28 |
Major Shareholding Notification
TR-1
|
English | 21.9 KB | ||
| 2025-06-06 16:12 |
Pre-Annual General Meeting Information
Notice of AGM and Annual Report & Accounts
|
English | 13.6 KB | ||
| 2025-06-04 15:34 |
Director's Dealing
Director/PDMR Shareholding
|
English | 32.6 KB | ||
| 2025-06-04 08:00 |
Earnings Release
Preliminary results for the year ended 31 Dec 2024
|
English | 543.9 KB | ||
| 2025-05-09 11:30 |
Major Shareholding Notification
TR-1
|
English | 21.9 KB | ||
| 2025-03-27 17:46 |
Earnings Release
PDS: Q4 Results and Clinical Programs Update
|
English | 26.6 KB | ||
| 2025-03-07 17:26 |
Regulatory News Service
PDS: VERSATILE-003 Phase 3 Clinical Trial
|
English | 22.1 KB | ||
| 2025-02-27 17:30 |
Share Issue/Capital Change
PDS: up to $22mn Registered Direct Offering
|
English | 17.4 KB | ||
| 2025-02-05 16:24 |
Regulatory News Service
PDS Biotech reaffirms guidance for clinical trial
|
English | 21.5 KB | ||
| 2025-02-03 08:00 |
Earnings Release
ProAxsis: Status Update and Proposed Fundraise
|
English | 19.2 KB |
Automate Your Workflow. Get a real-time feed of all EMV CAPITAL PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for EMV CAPITAL PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
